For several days, the Pfizer-BioNTech Covid-19 vaccine Comirnaty (BNT162b2) has dominated international headlines. From the market’s perspective, the most significant...
Sandoz, the generics division of Swiss drugmaker Novartis, is picking up GlaxoSmithKline’s cephalosporin antibiotics business, including the brands Zinnat, Zinacef and...
The IIoT continues to evolve, with countless solutions touting end-to-end process automation. However, one of the most important elements of IIoT — the human element —...
US-based CDMO Regis Technologies has completed a major expansion of its laboratory facilities for development of active pharmaceutical ingredients (APIs) at its site in...
US chemical company Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two distinct businesses during the fourth quarter of 2020.
As had been awaited, US healthcare giant Johnson & Johnson has applied to the European Medicines Authority (EMA) for conditional marketing authorization of its Covid-19...
Elkem, a Norwegian manufacturer of silicon-based advanced materials, has agreed to buy a brand-new production plant near Lyon in France. The identity of the seller was...
German CDMO Rentschler Biopharma is to establish manufacturing capacity for advanced therapy medicinal products (ATMPs), including Adeno-associated virus (AAV) vectors...
Germany’s Merck is investing €18 million at its new site in Tempe, Arizona, USA, including the purchase of the 28,000 m2 production facility leased by previous owner...
BioNTech this week kicked off production at the Marburg, Germany, plant it acquired last year from Novartis. The plant will focus on making mRNA batches, the beginning of...
